N oninfectious granulomatous diseases of the skin constitute a group of distinct, reactive inflammatory conditions that are often difficult to distinguish clinically and histologically. The granulomatous reactions represent immune reactions to an inciting antigen and may be associated with systemic disease.
1 Annular elastolytic giant cell granuloma (AEGCG) is a rare variant of the granulomatous skin diseases with destruction of elastic fibers after phagocytosis by histiocytes and multinucleated giant cells in the dermis. Typically, AEGCG is clinically characterized by solitary or grouped papules forming annular plaques with elevated borders and central atrophy. We report a case of AEGCG associated with oropharyngeal cancer.
CASE REPORT
A 62-year-old previously healthy man was referred from the department of oncology with an asymptomatic exanthema that had been present for 1 month. The patient was recently diagnosed with p16-positive squamous cell carcinoma in the right tonsil (T3, N0, M0) and treated with hyperfractionated radiation therapy. Physical examination found 3 demarcated papules coalescing into plaques located on the right side of his neck, chest, and right upper arm (Fig 1) . Histopathology findings of a skin biopsy from the chest showed a large area of the dermis infiltrated with histiocytes, including many nonpalisading foreign body giant cells, some lymphocytes, and few eosinophils. The foreign body giant cells had intracellular elastin fragments as evidence of elastophagocytosis. Corresponding to the infiltrated area, there was complete loss of elastin fibers visualized by orcein stain. There was no mucin or necrobiosis (Fig  2) . Type 2 diabetes was excluded by normal glycosylated hemoglobin. The findings were consistent with those of AEGCG. The skin lesions improved without treatment over months and were almost unnoticeable after 6 months.
DISCUSSION
AEGCG is typically observed in sun-exposed skin areas of otherwise healthy, middle-aged individuals. The lesions are asymptomatic and tend to resolve spontaneously without scaring over months to years. Some cases have been associated with malignancies, including acute myelogenous leukaemia, 2 adult T-cell leukaemia, 3 prostate carcinoma, 4 and primary cutaneous T-cell lymphoma. 5 In 2 of the case reports, the AEGCG regressed during treatment of the cancer. Thus, AEGCG may, by its nature, be paraneoplastic and has been proposed as a systemic immunologic host defense against the tumor antigen. 5 In this case, the patient was treated with radiation therapy before the skin symptoms emerged, and a possible connection cannot be excluded. However, we do believe the association to be temporal, as the patient had skin lesions outside the irradiated area on the neck. Furthermore, to our knowledge, AEGCG has not been associated with radiation therapy or other kinds of radiation.
Physicians should be aware that AEGCG may represent the presence of an underlying malignancy and perform a thorough clinical and paraclinical examination on patients with this skin manifestation. 
